Vona-Davis Linda, Yu Alice, Magabo Kristine, Evans Tracy, Jackson Barbara, Riggs Dale, McFadden David
Department of Surgery, West Virginia University, Morgantown, WV 26506, USA.
J Am Coll Surg. 2004 Jul;199(1):87-95. doi: 10.1016/j.jamcollsurg.2004.02.008.
Acute pancreatitis (AP) is a disease characterized by inflammation. Nuclear factor (NF)-kappaB, Smad proteins, and the steroid hormone family peroxisome proliferator-activated receptors (PPARs) are involved in regulation of gene transcription during the disease process. Peptide YY (PYY), a gastrointestinal hormone, inhibits NF-kappaB translocation to acinar nuclei in tumor necrosis factor (TNF)-alpha-induced AP. We investigated TNF-alpha induction of Smad proteins, PPARalpha/gamma, and NF-kappaB by TNF-alpha, and hypothesized that PYY would attenuate this effect.
Rat acinar cells were treated with recombinant TNF-alpha (200 ng/mL). PYY (3 to 36) was added at 500 pM at 30 minutes after TNF-alpha treatment until cell harvest at 2 hours. Western blot analysis and intracellular staining of the p65 subunit of NF-kappaB were performed. NF-kappaB, Smad3/4, and PPARalpha/gamma binding activities were determined by protein/DNA array analysis and verified by electrophoretic-mobility shift assay and densitometry.
Cellular localization of NF-kappaB p65 showed nuclear staining within 2 hours, with controls stained in the cytoplasm. With PYY, p65 stained in the cytoplasm. Nuclear p65 was increased significantly (p < 0.05) by TNF-alpha at 2 hours and PYY reduced it. Array analysis revealed upregulation of NF-kappaB, PPARalpha/gamma, and Smad3/4 with TNF-alpha. TNF-alpha stimulated NF-kappaB activation sevenfold, and binding was enhanced (p < 0.05). PYY reduced NF-kappaB binding to control levels. PPAR binding increased 51% after TNF-alpha treatment and was reduced to 33% with PYY. Smad3/4 binding was increased (p < 0.05) above controls with TNF-alpha and PYY reduced it by 40%.
TNF-alpha increases early nuclear translocation of the p65 subunit of NF-kappaB in acinar cells. Exposure to TNF-alpha activates transcription factors NF-kappaB, Smad3/4, and PPARalpha/gamma. PYY reduces this activation. Treatment with PYY may have therapeutic potential in improving AP.
急性胰腺炎(AP)是一种以炎症为特征的疾病。核因子(NF)-κB、Smad蛋白以及类固醇激素家族过氧化物酶体增殖物激活受体(PPARs)参与了该疾病过程中的基因转录调控。肽YY(PYY)是一种胃肠激素,可抑制肿瘤坏死因子(TNF)-α诱导的急性胰腺炎中NF-κB向腺泡细胞核的转位。我们研究了TNF-α对Smad蛋白、PPARα/γ和NF-κB的诱导作用,并假设PYY会减弱这种作用。
用重组TNF-α(200 ng/mL)处理大鼠腺泡细胞。在TNF-α处理30分钟后,以500 pM的浓度加入PYY(3 - 36),直至2小时后收获细胞。进行NF-κB p65亚基的蛋白质印迹分析和细胞内染色。通过蛋白质/DNA阵列分析测定NF-κB、Smad3/4和PPARα/γ的结合活性,并通过电泳迁移率变动分析和光密度测定进行验证。
NF-κB p65的细胞定位显示,2小时内核染色,而对照组在细胞质中染色。使用PYY时,p65在细胞质中染色。2小时时,TNF-α使核p65显著增加(p < 0.05),而PYY使其降低。阵列分析显示,TNF-α使NF-κB、PPARα/γ和Smad3/4上调。TNF-α刺激NF-κB激活7倍,结合增强(p < 0.05)。PYY将NF-κB结合降低至对照水平。TNF-α处理后PPAR结合增加51%,而使用PYY后降至33%。TNF-α使Smad3/4结合高于对照水平增加(p < 0.05),而PYY使其降低40%。
TNF-α增加腺泡细胞中NF-κB p65亚基的早期核转位。暴露于TNF-α会激活转录因子NF-κB、Smad3/4和PPARα/γ。PYY可减弱这种激活。用PYY治疗可能对改善急性胰腺炎具有治疗潜力。